Mice Model Market Expected to Reach Usd 1.75 Billion in 2023

According to a new market report published by Transparency Market Research “Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, the global mice model market was valued at USD 1.01 billion in 2013 and is anticipated to expand at a CAGR of 6.4% from 2015 to 2023 to reach USD 1.75 billion by 2023.

Get the Full Report at:

http://www.transparencymarketresearch.com/mice-model-market.html

Mice have been one of the most important research tools for basic and applied research in biomedical sciences and continues to grow at a rapid rate. Besides providing precise correlation with human condition, the major advantage of mice models is the prospect of exploring precise gene-specific functions and various molecular events in a living organism. Combining mice models with advanced imaging technologies provide unique opportunities to understand the etiology and pathophysiology of human diseases. Furthermore, mice have been widely used in biomedical research to discover human diseases and to evaluate new drug candidates. Mouse research has led to major advances in treating a number of diseases and conditions. For example, experiments on mice models resulted in efficacious treatments for acute promyelocytic leukemia, or APL, which was largely terminal.

An expanding collection of gene technology, together with sequencing of the mice genome and biological conservation, place the mouse at the leading position as a model to decode mechanisms underlying human disease progression. More than any other genetically tractable research animal, mice offer a close view of human biology in terms of resemblance with the pathophysiology, cellular structure, and organization. With 99% of their genes shared with humans, new possibilities were opened in genetic testing, drug discovery, and other basic research. Furthermore, the conservation of genetic association within the mice and human genomes with respect to the encoded genes and their...